The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
OTC Medicine-Global Market Insights and Sales Trends 2024
Synopsis
OTC medicines are also called over-the-counter drugs, as opposed to prescription drugs, which refer to drugs that can be purchased from pharmacies without a doctor's prescription. These drugs have been used for a long time in clinical practice, with definite efficacy and fewer adverse drug reactions. Patients do not need to have too much professional knowledge, and they can use them safely with only the drug instructions and labels.
The global OTC Medicine market size is expected to reach US$ 37700 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of OTC Medicine in various end use industries. The expanding demands from the Pharmacy, Hospital Pharmacy, Online Retailer and Others, are propelling OTC Medicine market. Gastrointestinal Tract, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dermatology segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for OTC Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global OTC Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global OTC Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, OTC Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of OTC Medicine covered in this report include Procter & Gamble, Johnson & Johnson, GlaxoSmithKline Plc, Abbott Laboratories, Amway Corporation, Bayer, Aktienge, Sanofi and Pfizer, etc.
The global OTC Medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Procter & Gamble
Johnson & Johnson
GlaxoSmithKline Plc
Abbott Laboratories
Amway Corporation
Bayer
Aktienge
Sanofi
Pfizer
Reckitt Benckiser Group
Church & Dwight
Bayer HealthCare
AstraZeneca
BioGaia
Bristol Myers Squibb
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Global OTC Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global OTC Medicine market, Segment by Type:
Gastrointestinal Tract
Dermatology
Otolaryngology
Nutrition/Vitamins
Others
Global OTC Medicine market, by Application
Pharmacy
Hospital Pharmacy
Online Retailer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of OTC Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of OTC Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
OTC medicines are also called over-the-counter drugs, as opposed to prescription drugs, which refer to drugs that can be purchased from pharmacies without a doctor's prescription. These drugs have been used for a long time in clinical practice, with definite efficacy and fewer adverse drug reactions. Patients do not need to have too much professional knowledge, and they can use them safely with only the drug instructions and labels.
The global OTC Medicine market size is expected to reach US$ 37700 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of OTC Medicine in various end use industries. The expanding demands from the Pharmacy, Hospital Pharmacy, Online Retailer and Others, are propelling OTC Medicine market. Gastrointestinal Tract, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dermatology segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for OTC Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global OTC Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global OTC Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, OTC Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of OTC Medicine covered in this report include Procter & Gamble, Johnson & Johnson, GlaxoSmithKline Plc, Abbott Laboratories, Amway Corporation, Bayer, Aktienge, Sanofi and Pfizer, etc.
The global OTC Medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Procter & Gamble
Johnson & Johnson
GlaxoSmithKline Plc
Abbott Laboratories
Amway Corporation
Bayer
Aktienge
Sanofi
Pfizer
Reckitt Benckiser Group
Church & Dwight
Bayer HealthCare
AstraZeneca
BioGaia
Bristol Myers Squibb
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Global OTC Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global OTC Medicine market, Segment by Type:
Gastrointestinal Tract
Dermatology
Otolaryngology
Nutrition/Vitamins
Others
Global OTC Medicine market, by Application
Pharmacy
Hospital Pharmacy
Online Retailer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of OTC Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of OTC Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 OTC Medicine Market Overview
1.1 OTC Medicine Product Overview
1.2 OTC Medicine Market Segment by Type
1.2.1 Gastrointestinal Tract
1.2.2 Dermatology
1.2.3 Otolaryngology
1.2.4 Nutrition/Vitamins
1.2.5 Others
1.3 Global OTC Medicine Market Size by Type
1.3.1 Global OTC Medicine Market Size Overview by Type (2018-2029)
1.3.2 Global OTC Medicine Historic Market Size Review by Type (2018-2023)
1.3.3 Global OTC Medicine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America OTC Medicine Sales Breakdown by Type (2018-2023)
1.4.2 Europe OTC Medicine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific OTC Medicine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America OTC Medicine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa OTC Medicine Sales Breakdown by Type (2018-2023)
2 Global OTC Medicine Market Competition by Company
2.1 Global Top Players by OTC Medicine Sales (2018-2023)
2.2 Global Top Players by OTC Medicine Revenue (2018-2023)
2.3 Global Top Players by OTC Medicine Price (2018-2023)
2.4 Global Top Manufacturers OTC Medicine Manufacturing Base Distribution, Sales Area, Product Type
2.5 OTC Medicine Market Competitive Situation and Trends
2.5.1 OTC Medicine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by OTC Medicine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in OTC Medicine as of 2022)
2.7 Date of Key Manufacturers Enter into OTC Medicine Market
2.8 Key Manufacturers OTC Medicine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 OTC Medicine Status and Outlook by Region
3.1 Global OTC Medicine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global OTC Medicine Historic Market Size by Region
3.2.1 Global OTC Medicine Sales in Volume by Region (2018-2023)
3.2.2 Global OTC Medicine Sales in Value by Region (2018-2023)
3.2.3 Global OTC Medicine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global OTC Medicine Forecasted Market Size by Region
3.3.1 Global OTC Medicine Sales in Volume by Region (2024-2029)
3.3.2 Global OTC Medicine Sales in Value by Region (2024-2029)
3.3.3 Global OTC Medicine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global OTC Medicine by Application
4.1 OTC Medicine Market Segment by Application
4.1.1 Pharmacy
4.1.2 Hospital Pharmacy
4.1.3 Online Retailer
4.1.4 Others
4.2 Global OTC Medicine Market Size by Application
4.2.1 Global OTC Medicine Market Size Overview by Application (2018-2029)
4.2.2 Global OTC Medicine Historic Market Size Review by Application (2018-2023)
4.2.3 Global OTC Medicine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America OTC Medicine Sales Breakdown by Application (2018-2023)
4.3.2 Europe OTC Medicine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific OTC Medicine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America OTC Medicine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa OTC Medicine Sales Breakdown by Application (2018-2023)
5 North America OTC Medicine by Country
5.1 North America OTC Medicine Historic Market Size by Country
5.1.1 North America OTC Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America OTC Medicine Sales in Volume by Country (2018-2023)
5.1.3 North America OTC Medicine Sales in Value by Country (2018-2023)
5.2 North America OTC Medicine Forecasted Market Size by Country
5.2.1 North America OTC Medicine Sales in Volume by Country (2024-2029)
5.2.2 North America OTC Medicine Sales in Value by Country (2024-2029)
6 Europe OTC Medicine by Country
6.1 Europe OTC Medicine Historic Market Size by Country
6.1.1 Europe OTC Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe OTC Medicine Sales in Volume by Country (2018-2023)
6.1.3 Europe OTC Medicine Sales in Value by Country (2018-2023)
6.2 Europe OTC Medicine Forecasted Market Size by Country
6.2.1 Europe OTC Medicine Sales in Volume by Country (2024-2029)
6.2.2 Europe OTC Medicine Sales in Value by Country (2024-2029)
7 Asia-Pacific OTC Medicine by Region
7.1 Asia-Pacific OTC Medicine Historic Market Size by Region
7.1.1 Asia-Pacific OTC Medicine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific OTC Medicine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific OTC Medicine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific OTC Medicine Forecasted Market Size by Region
7.2.1 Asia-Pacific OTC Medicine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific OTC Medicine Sales in Value by Region (2024-2029)
8 Latin America OTC Medicine by Country
8.1 Latin America OTC Medicine Historic Market Size by Country
8.1.1 Latin America OTC Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America OTC Medicine Sales in Volume by Country (2018-2023)
8.1.3 Latin America OTC Medicine Sales in Value by Country (2018-2023)
8.2 Latin America OTC Medicine Forecasted Market Size by Country
8.2.1 Latin America OTC Medicine Sales in Volume by Country (2024-2029)
8.2.2 Latin America OTC Medicine Sales in Value by Country (2024-2029)
9 Middle East and Africa OTC Medicine by Country
9.1 Middle East and Africa OTC Medicine Historic Market Size by Country
9.1.1 Middle East and Africa OTC Medicine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa OTC Medicine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa OTC Medicine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa OTC Medicine Forecasted Market Size by Country
9.2.1 Middle East and Africa OTC Medicine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa OTC Medicine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Procter & Gamble
10.1.1 Procter & Gamble Company Information
10.1.2 Procter & Gamble Introduction and Business Overview
10.1.3 Procter & Gamble OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Procter & Gamble OTC Medicine Products Offered
10.1.5 Procter & Gamble Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson & Johnson OTC Medicine Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 GlaxoSmithKline Plc
10.3.1 GlaxoSmithKline Plc Company Information
10.3.2 GlaxoSmithKline Plc Introduction and Business Overview
10.3.3 GlaxoSmithKline Plc OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Plc OTC Medicine Products Offered
10.3.5 GlaxoSmithKline Plc Recent Development
10.4 Abbott Laboratories
10.4.1 Abbott Laboratories Company Information
10.4.2 Abbott Laboratories Introduction and Business Overview
10.4.3 Abbott Laboratories OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Abbott Laboratories OTC Medicine Products Offered
10.4.5 Abbott Laboratories Recent Development
10.5 Amway Corporation
10.5.1 Amway Corporation Company Information
10.5.2 Amway Corporation Introduction and Business Overview
10.5.3 Amway Corporation OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Amway Corporation OTC Medicine Products Offered
10.5.5 Amway Corporation Recent Development
10.6 Bayer
10.6.1 Bayer Company Information
10.6.2 Bayer Introduction and Business Overview
10.6.3 Bayer OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bayer OTC Medicine Products Offered
10.6.5 Bayer Recent Development
10.7 Aktienge
10.7.1 Aktienge Company Information
10.7.2 Aktienge Introduction and Business Overview
10.7.3 Aktienge OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Aktienge OTC Medicine Products Offered
10.7.5 Aktienge Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi OTC Medicine Products Offered
10.8.5 Sanofi Recent Development
10.9 Pfizer
10.9.1 Pfizer Company Information
10.9.2 Pfizer Introduction and Business Overview
10.9.3 Pfizer OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Pfizer OTC Medicine Products Offered
10.9.5 Pfizer Recent Development
10.10 Reckitt Benckiser Group
10.10.1 Reckitt Benckiser Group Company Information
10.10.2 Reckitt Benckiser Group Introduction and Business Overview
10.10.3 Reckitt Benckiser Group OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Reckitt Benckiser Group OTC Medicine Products Offered
10.10.5 Reckitt Benckiser Group Recent Development
10.11 Church & Dwight
10.11.1 Church & Dwight Company Information
10.11.2 Church & Dwight Introduction and Business Overview
10.11.3 Church & Dwight OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Church & Dwight OTC Medicine Products Offered
10.11.5 Church & Dwight Recent Development
10.12 Bayer HealthCare
10.12.1 Bayer HealthCare Company Information
10.12.2 Bayer HealthCare Introduction and Business Overview
10.12.3 Bayer HealthCare OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bayer HealthCare OTC Medicine Products Offered
10.12.5 Bayer HealthCare Recent Development
10.13 AstraZeneca
10.13.1 AstraZeneca Company Information
10.13.2 AstraZeneca Introduction and Business Overview
10.13.3 AstraZeneca OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 AstraZeneca OTC Medicine Products Offered
10.13.5 AstraZeneca Recent Development
10.14 BioGaia
10.14.1 BioGaia Company Information
10.14.2 BioGaia Introduction and Business Overview
10.14.3 BioGaia OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 BioGaia OTC Medicine Products Offered
10.14.5 BioGaia Recent Development
10.15 Bristol Myers Squibb
10.15.1 Bristol Myers Squibb Company Information
10.15.2 Bristol Myers Squibb Introduction and Business Overview
10.15.3 Bristol Myers Squibb OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Bristol Myers Squibb OTC Medicine Products Offered
10.15.5 Bristol Myers Squibb Recent Development
10.16 Chr. Hansen
10.16.1 Chr. Hansen Company Information
10.16.2 Chr. Hansen Introduction and Business Overview
10.16.3 Chr. Hansen OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Chr. Hansen OTC Medicine Products Offered
10.16.5 Chr. Hansen Recent Development
10.17 Cipla
10.17.1 Cipla Company Information
10.17.2 Cipla Introduction and Business Overview
10.17.3 Cipla OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Cipla OTC Medicine Products Offered
10.17.5 Cipla Recent Development
10.18 CoLucid
10.18.1 CoLucid Company Information
10.18.2 CoLucid Introduction and Business Overview
10.18.3 CoLucid OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.18.4 CoLucid OTC Medicine Products Offered
10.18.5 CoLucid Recent Development
10.19 Daiichi Sankyo
10.19.1 Daiichi Sankyo Company Information
10.19.2 Daiichi Sankyo Introduction and Business Overview
10.19.3 Daiichi Sankyo OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Daiichi Sankyo OTC Medicine Products Offered
10.19.5 Daiichi Sankyo Recent Development
10.20 Friggs
10.20.1 Friggs Company Information
10.20.2 Friggs Introduction and Business Overview
10.20.3 Friggs OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Friggs OTC Medicine Products Offered
10.20.5 Friggs Recent Development
10.21 DSM
10.21.1 DSM Company Information
10.21.2 DSM Introduction and Business Overview
10.21.3 DSM OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.21.4 DSM OTC Medicine Products Offered
10.21.5 DSM Recent Development
10.22 Eisai
10.22.1 Eisai Company Information
10.22.2 Eisai Introduction and Business Overview
10.22.3 Eisai OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.22.4 Eisai OTC Medicine Products Offered
10.22.5 Eisai Recent Development
10.23 Eli Lilly
10.23.1 Eli Lilly Company Information
10.23.2 Eli Lilly Introduction and Business Overview
10.23.3 Eli Lilly OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.23.4 Eli Lilly OTC Medicine Products Offered
10.23.5 Eli Lilly Recent Development
10.24 Herbalife
10.24.1 Herbalife Company Information
10.24.2 Herbalife Introduction and Business Overview
10.24.3 Herbalife OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.24.4 Herbalife OTC Medicine Products Offered
10.24.5 Herbalife Recent Development
10.25 Euradite
10.25.1 Euradite Company Information
10.25.2 Euradite Introduction and Business Overview
10.25.3 Euradite OTC Medicine Sales, Revenue and Gross Margin (2018-2023)
10.25.4 Euradite OTC Medicine Products Offered
10.25.5 Euradite Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 OTC Medicine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 OTC Medicine Industrial Chain Analysis
11.4 OTC Medicine Market Dynamics
11.4.1 OTC Medicine Industry Trends
11.4.2 OTC Medicine Market Drivers
11.4.3 OTC Medicine Market Challenges
11.4.4 OTC Medicine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 OTC Medicine Distributors
12.3 OTC Medicine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
